/ Our Company/Board of Directors Stanley M. Bergman Chairman of the Board and Chief Executive Officer | Read more Barry J. Alperin Retired Vice Chairman, Hasbro, Inc. | Read more Lawrence S. Bacow, Ph.D. Leader-in-Residence, Center for Public Leadership at Harvard's Kennedy School of Government; and Finance Chair of the Fiduciary Oversight Board of the Harvard Corporation | Read more Gerald A. Benjamin Executive Vice President, Chief Administrative Officer | Read more James P. Breslawski President, Henry Schein, Inc., and CEO, Global Dental Group | Read more Paul Brons Former President of Organon International BV | Read more Joseph L. Herring Former Chief Executive Officer Covance, Inc. | Read more Donald J. Kabat Former Chief Financial Officer of Central Park Skaters, Inc.; Former President of D.J.K. Consulting Services, Inc.; and Retired Partner, Accenture PLC Ireland | Read more Kurt P. Kuehn Former Chief Financial Officer of United Parcel Service, Inc. | Read more Philip A. Laskawy Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP) | Read more Mark E. Mlotek Executive Vice President, Chief Strategic Officer | Read more Steven Paladino Executive Vice President, Chief Financial Officer | Read more Carol Raphael Senior Advisor for Manatt Health Solutions; and Former President and CEO, Visiting Nurse Service of New York | Read more E. Dianne Rekow, DDS, Ph.D. Former Dean of the Dental Institute at King's College London and Professor of Orthodontics; Former Professor of Orthodontics, Senior Vice Provost of Engineering Technology and Provost of Polytechnic Institute at New York University | Read more Bradley T. Sheares, Ph.D. Former CEO, Reliant Pharmaceuticals; and Former President of U.S. Human Health for Merck & Co. | Read more Chairman of the Board and Chief Executive Officer Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, with more than 22,000 Team Schein Members and operations or affiliates in 33 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2016, the Company's sales reached a record $11.6 billion. Henry Schein has been a Fortune World's Most Admired Company for 16 consecutive years. Mr. Bergman serves as a board member or advisor for numerous institutions, including New York University College of Dentistry, the University of Pennsylvania School of Dental Medicine, the Columbia University Medical Center, University of the People, Hebrew University, Tel Aviv University, the University of the Witwatersrand Fund, The World Economic Forum's Health Care Governors, the Business Council for International Understanding, the Japan Society, and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega International Dental Fraternity. He is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Hofstra University, A.T. Still University's Arizona School of Dentistry and Oral Health, Case Western Reserve University, and Farmingdale State College (SUNY); and Honorary Fellowships from King's College London - Dental Institute and the International College of Dentists. Stan and Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity, and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa, and other developing regions of the world. Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant and a NYS Certified Public Accountant. Articles Why the iPhone May Not Be the Best Device, But Something Better: the Most Important 5 Pieces of Advice to Summer Interns...and Anyone Who Wants Happiness at Work Preserving Our Unique American DNA in a Time of Rapid Change A Dinner Party for Democracy 10 Lessons to the Class of 2017 Videos Stanley Bergman Accepts CEO of the Year Award from Chief Executive Magazine Stanley Bergman on CNBC: 'Anything to Do With Digital' is Growing Rapidly in Health Care Stanley Bergman on Fox Business News: Keeping Americans Out of Hospitals Through Wellness and Prevention Stanley Bergman on CNBC: Regulations Should be Equal Throughout the World Stanley Bergman on CNBC Africa: World Economic Forum in Davos Henry Schein CEO: Staying Strong | Mad Money | CNBC. Henry Schein CEO: Digital Transformation | Mad Money | CNBC. Retired Vice Chairman, Hasbro, Inc. Mr. Alperin has been a director of Henry Schein, Inc. since 1996. He joined Hasbro, Inc. in 1995 and served in various senior executive officer positions, ultimately as Vice Chairman of Hasbro, Inc. from 1990 until his retirement in 1995. Prior to this, Mr. Alperin practiced law in New York City for 20 years, dealing with corporate, public and private financial transactions, corporate mergers and acquisitions, compensation issues, and securities law matters. Mr. Alperin currently serves as a director of Fiesta Restaurant Group, Inc. and is Chairman of its finance committee and a member of its audit committee and nominating and governance committee. He is also a director at Jefferies Group LLC and is a member of its audit committee, compensation committee and corporate governance and nominating committee. Mr. Alperin is also a director of privately held corporations Weeks Marine, Inc. and Sterling Drive Ventures, Inc., and a general partner of Sterling Drive Ventures L.P., a holding company for the Rodan Group. He currently serves as a trustee and member of the Executive Committee of The Caramoor Center for Music and the Arts, President Emeritus and a Life Trustee of The Jewish Museum in New York City, and is a past President of the New York Chapter of the American Jewish Committee, where he also served as Chair of the audit committee of the national organization. Mr. Alperin graduated from Dartmouth College, magna cum laude and Phi Beta Kappa, holds an MBA with High Distinction from The Amos Tuck School of Business Administration, and is a cum laude graduate of the Harvard Law School. He resides in New York City. Leader-in-Residence, Center for Public Leadership at Harvard's Kennedy School of Government; and Finance Chair of the Fiduciary Oversight Board of the Harvard Corporation Dr. Bacow has been a director of the Company since 2014 and is currently Leader-in-Residence at the Center for Public Leadership at Harvard's Kennedy School of Government. He is also a member of the Harvard Corporation, the fiduciary oversight board of Harvard University, where he chairs the finance committee. From 2001 to 2011, Dr. Bacow was the 12th President of Tufts University, where he oversaw all seven of the University's schools, including its School of Dental Medicine, School of Medicine, and the Cummings School of Veterinary Medicine. In addition, he served on the Board of Trustees and as a member of the executive committee of Tufts Medical Center. Following Tufts, Dr. Bacow served as President-in-Residence in the Higher Education Program at Harvard's Graduate School of Education for three years. Earlier in his career, Dr. Bacow spent 24 years on the faculty at the Massachusetts Institute of Technology, where he held the Lee and Geraldine Martin Professorship of Environmental Studies. He also served as the elected Chair of the MIT Faculty and subsequently as Chancellor. Dr. Bacow is on the Board of Overseers of TIAA-CREF and is a director of Liquidnet Holdings, Inc., serving on the audit committee of both Boards. Dr. Bacow received an S.B. in economics from the Massachusetts Institute of Technology, a J.D. from Harvard Law School, and a M.P.P. and a Ph.D. from Harvard's Kennedy School of Government. He is a Fellow of the American Academy of Arts and Sciences and the recipient of five honorary degrees. Executive Vice President, Chief Administrative Officer Mr. Benjamin has been with Henry Schein, Inc. since 1988. He has served in his current position as Executive Vice President and Chief Administrative Officer since 2000 and as a director since 1994. He is a member of the Executive Management Committee and the Company's liaison to the Board's Compensation Committee. Prior to holding his current position, Mr. Benjamin was Senior Vice President of Administration and Customer Satisfaction from 1993 to 2000. He was Vice President of Distribution Operations from 1990 to 1992 and Director of Materials Management from 1988 to 1990. In his current position, Mr. Benjamin directs the Company's Global Services functions throughout North America, South America, Europe, Asia, Australia and New Zealand. These functions include all aspects of the Supply Chain (Distribution, Inventory Management, and Transportation), Human Resources, Information Services, Customer Services, Security, and Financial Operations. Under Mr. Benjamin's leadership, the Company has led the industry in worldwide distribution efficiency and accuracy. Mr. Benjamin also guides all aspects of human resources and organizational development for more than 22,000 Team Schein Members in 33 countries around the world. In addition to spearheading innovative professional development initiatives, Mr. Benjamin has ensured that the Company's unique values-based culture has been preserved and strengthened as the organization has experienced exponential growth through scores of strategic global acquisitions. This culture is marked by Henry Schein's commitment to social responsibility. Mr. Benjamin currently sits as a member of the Board of Directors of the Henry Schein Cares Foundation and has directed all internally driven programs for Henry Schein Cares, the Company's global corporate social responsibility program, including Back to School and Holiday Cheer for Children, two annual flagship programs that give back to the less fortunate. In 2014, Mr. Benjamin was honored as an Ellis Island Medal of Honor recipient for founding Henry Schein Cares and for his support of YAI (Young Adult Institute), which serves individuals with disabilities. Mr. Benjamin was also honored for his work with MCW (Miracle Corners of the World), which empowers young people to become positive agents for change in their communities. Prior to joining the Company, Mr. Benjamin served in a series of positions with increasing responsibility in 12 years with Estée Lauder, Inc., leaving that company as Director of Material Planning & Control. Mr. Benjamin earned a bachelor's degree in electrical engineering at the City College of New York, and an MBA in marketing at Fordham University at Lincoln Center. President, Henry Schein, Inc., and CEO, Global Dental Group Mr. Breslawski has been with Henry Schein, Inc. since 1980. He has served in his current position as President of Henry Schein, Inc. since 2005 and as a director since 1992. He is a member of the Executive Management Committee and also holds the role of Chief Executive Officer of Henry Schein's Global Dental Group. Mr. Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group. Between 1980 and 1990, Mr. Breslawski held various positions, including Chief Financial Officer, Vice President of Finance and Administration, and Corporate Controller. Mr. Breslawski is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He is currently a Member of the Leadership Council the Harvard School of Dental Medicine. He previously served as a Member of the Board of Governors for St. John's University, a Trustee of the Long Island University Board, and a Board Member of the National Foundation of Dentistry for the Handicapped. Mr. Breslawski also has served as Chairman of the Board of the American Dental Trade Association and President of the Dental Dealers of America, both of which became part of the Dental Trade Alliance, where he also served as Chairman. In addition he served as Chairman of the Dental Trade Alliance Foundation. Prior to joining Henry Schein, Mr. Breslawski was a certified public accountant at the national professional services firm BDO Seidman, LLP. He received his degree in accounting from St. John's University. Former President of Organon International BV Mr. Brons has been a director of Henry Schein, Inc. since 2005. A member of the Akzo Nobel Board of Management from 1994 to 2002, he led all of the company's pharmaceutical business units, including human and veterinary pharmaceuticals, OTCs, generics, diagnostics, and pharmaceutical active ingredients. Earlier in his career he held various positions with Organon International BV, including President from 1983 to 1994 and Deputy President from 1979 to 1983. Since retiring from the Akzo Nobel N.V. Board of Management in 2002, Mr. Brons has served on the Supervisory Boards for Akzo Nobel Netherlands, Organon BioSciences Netherlands, and IBM Corporation Netherlands. He was honored in 1996 by Her Majesty the Queen with the decoration of Knight of the Order of Lion of the Kingdom of the Netherlands, the country's highest civilian order, conferred for his meritorious achievements for Akzo Nobel and other international activities. Former Chief Executive Officer Covance, Inc. Mr. Herring has been a director of Henry Schein, Inc. since 2016. He served as Chief Executive Officer of Covance, Inc. from 2005 to 2015 and as Chairman of its Board of Directors from 2006 until its acquisition by Laboratory Corporation of America, Inc. in 2015. Prior to joining Covance, Mr. Herring held a variety of senior leadership positions with Caremark International and American Hospital Supply Corporation over the course of his 19 years with the combined companies. He currently serves on the nonprofit board for University Medical Center of Princeton and previously served on the board of the Association of Clinical Research Organizations, of which he served as chairman. He is a former director of Team Health Holdings, Inc. Mr. Herring received a Bachelor of Science in marketing from Louisiana State University. Former Chief Financial Officer of Central Park Skaters, Inc.; Former President of D.J.K. Consulting Services, Inc.; and Retired Partner, Accenture PLC Ireland Mr. Kabat has been a director of Henry Schein, Inc. since 1996. He was the Chief Financial Officer of Central Park Skaters, Inc. from 1992 to 1995 and the President of D.J.K. Consulting Services, Inc. from 1995 to 2006. From 1970 to 1992, Mr. Kabat was a partner in Andersen Consulting (now known as Accenture PLC Ireland), where he practiced a broad array of specialty services including organization, profit improvement, process re-engineering, and cost-justification studies. During his career with Andersen Consulting, Mr. Kabat helped launch an entirely new practice specialty called Change Management Services. He was the recipient of the “Bravos” award for outstanding contribution to the Change Management practice. He has made numerous speeches, written articles, and contributed chapters to specialized books (e.g., Budgeting: Key to Planning and Control; Management Controls for Professional Firms and The Change Management Handbook). He also serves on the boards, and chairs committees, of several not-for-profit organizations. Mr. Kabat received his bachelor's degree from Antioch College and a master's degree from Columbia University School of Business. He majored in accounting, became a Certified Public Accountant and joined Andersen Consulting after serving in the United States Army. Former Chief Financial Officer of United Parcel Service, Inc. Mr. Kuehn has been a director of Henry Schein, Inc. since 2016. He was Chief Financial Officer of United Parcel Service, Inc. ("UPS"), a global leader in logistics, from 2008 until 2015. Prior to his appointment as CFO, Mr. Kuehn was Senior Vice President, Worldwide Sales and Marketing, leading the transformation of the sales organization to improve the global customer experience. Mr. Kuehn was UPS's first Vice President of Investor Relations, taking the company public in 1999 in one of the largest IPOs in U.S. history. Since he joined UPS as a driver in 1977, Mr. Kuehn's UPS career included leadership roles in sales and marketing, engineering, operations, and strategic cost planning. Mr. Kuehn is also a director at NCR Corporation and is Chair of its audit committee and a member of its executive committee. Mr. Kuehn graduated from Yale University, received a Master of Business Administration from the University of Miami, and completed an advanced management program from the Wharton School of Business. Lead Director, Henry Schein, Inc.; and Retired Chairman, Ernst & Young, LLP (now known as EY LLP) Mr. Laskawy has been a director of Henry Schein, Inc. since 2002, and has served as Lead Director since 2012. Mr. Laskawy spent 40 years at Ernst & Young (now known as EY LLP), retiring as Chairman and CEO of the Company in 2001. Under his leadership, the firm expanded into a global leader in assurance, tax, transaction, and advisory services. Mr. Laskawy joined Ernst & Young in 1961 after graduating from the Wharton School of the University of Pennsylvania with a Bachelor's degree in Economics. Progressing through the ranks of the audit services practice, he was admitted to the firm's partnership in 1971. He became Managing Partner of the New York Office in 1981, and in 1985 was named Vice Chairman and Managing Partner of the New York Region and a member of the firm's Management Committee. Mr. Laskawy became Chairman and CEO of Ernst & Young in 1994 and held that position until his retirement. Mr. Laskawy currently serves on the Board of Directors of Lazard Ltd. and is Chairman of its audit committee and is a member of its compensation committee. He is also a director at Loews Corporation and is a member of its audit committee. Mr. Laskawy served on the American Institute of Certified Public Accountants to review and update rules regarding auditor independence. In 2006 and 2007, he served as Chairman and Vice Chairman of the International Accounting Standards Committee Foundation, which was created by the Securities and Exchange Commission and sets accounting standards in more than 100 countries, and he served as a member of the 1999 Blue Ribbon Committee on Improving the Effectiveness of Corporate Audit Committees. Mr. Laskawy has also served on the Board of Directors of General Motors Corporation and was the Non-Executive Chairman of Federal National Mortgage Association (Fannie Mae). Executive Vice President, Chief Strategic Officer Mr. Mlotek has been with Henry Schein, Inc. since 1994, serving in his current position as Executive Vice President and Chief Strategic Officer since 2012 and as a director since 1995. He is also a member of the Executive Management Committee. In his current role, Mr. Mlotek has three main priorities: worldwide merger and acquisition activity for the Company; business development, including important supplier partnership arrangements; and worldwide strategic planning. Prior to holding his current position, Mr. Mlotek served as the Company's Senior Vice President of Corporate Business Development, and before that, upon joining the Company in 1994, was Vice President, General Counsel, and Secretary. Prior to joining Henry Schein, Mr. Mlotek was a partner in the law firm of Proskauer Rose, LLP and counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations, and tax law. At Proskauer, since 1989, Mr. Mlotek worked very closely with Henry Schein on various corporate matters. Prior to joining Proskauer, Mr. Mlotek was a partner in the law firm of Feit & Ahrens. Mr. Mlotek graduated from the Columbia University School of Law with high honors in 1980. He received an LL.M. in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, many of which help the perpetuation of the Yiddish language and culture. From 1996-2000, he served on the Conference of Presidents of Major American Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association. Executive Vice President, Chief Financial Officer Mr. Paladino has held the position of Executive Vice President and Chief Financial Officer at Henry Schein since 2000, and has been Chief Financial Officer since 1993. From 1990 to 1992, he served as Vice President and Treasurer, and from 1987 to 1990, served as Corporate Controller. A certified public accountant, he was with BDO Seidman, LLP as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987. Mr. Paladino's responsibilities include corporate oversight of business units as well as direct responsibility for Corporate Finance. These corporate services include Financial Reporting, Financial Planning, Treasury, Investor Relations, Internal Audit, Risk Management, and Taxation. He also has responsibility for Henry Schein Financial Services, which provides financial business services to Henry Schein's customers and works with the Corporate Business Development Group on Mergers and Acquisition activities. Mr. Paladino led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995. He has been a Member of the Board of Directors of Henry Schein, Inc. since 1994 and a Member of the Executive Management Committee since 1992. Mr. Paladino is also a member of the American Institute of CPAs, NYS Society of CPAs and the Institute of Management Accountants. Mr. Paladino serves as Board Member for MSC Industrial Supply Co and is a member of its audit committee and compensation committee. He also served as a Nasdaq Listing and Hearing Review Council member. The Listing and Hearing Review Council provides advice to the Board of Directors of The Nasdaq Stock Market LLC on issues relating to listing rule and policy changes and enhancements that will protect investors and the integrity of the Nasdaq Stock Market, while ensuring the consistent and fair application and enforcement of the listing rules, procedures and policies of Nasdaq. Mr. Paladino is the recipient of the following recognitions and awards: 1996 Financial Executive of the Year – Institute of Management Accountants 2009 Institutional Investor's America's Best CFOs – Healthcare Technology & Distribution Sector 2012 Institutional Investor's America's Best CFOs – Healthcare Technology & Distribution Sector 2013 CFO Lifetime Achievement Award, Long Island Business News 2016 Institutional Investor's All-America Executive Team, ranked #2 CFO for Healthcare Technology & Distribution Sector, by the sell-side 2017 Institutional Investor's All-America Executive Team, ranked #2 CFO overall for Healthcare Technology & Distribution Sector, ranked #3 by buy-side and #2 by sell-side Mr. Paladino holds a bachelor of business administration degree from Bernard M. Baruch College. Senior Advisor for Manatt Health Solutions; and Former President and CEO, Visiting Nurse Service of New York Ms. Raphael has been a director of Henry Schein, Inc. since 2012. She currently serves as a Senior Advisor for Manatt Health Solutions. Ms. Raphael served as the President and Chief Executive Officer of the Visiting Nurse Service of New York from 1989 to 2011. Prior to this, she held executive positions at Mt. Sinai Medical Center and in New York City government. Ms. Raphael has served on the Federal Bipartisan Commission on Long Term Care, the Medicare Payment Advisory Commission (MedPAC), the New York State Medicaid Redesign Team, and was an Advanced Leadership Fellow at Harvard University. She is the Chair of the Board of the Long Term Quality Alliance and a board member of the New York eHealth Collaborative, which is implementing a statewide, standardized platform for the exchange of health information. She chaired the National Quality Forum's Post-Acute, Long Term Care, and Hospice Workgroup, which brought together stakeholders to recommend quality measures as federal programs move to public reporting and value-based purchasing. She is co-chair of its Attribution Committee and a member of its All-Cause Admissions and Readmissions Standing Committee. She also co-chaired the West Health Advisory Council on Emergency Department to Home-Based Healthcare. Ms. Raphael currently serves on several non-profit boards including the Primary Care Development Corporation, the Medicare Rights Center, the SCAN Foundation, Commonwealth Care Alliance, and in 2016, completed her term as Chair of the national AARP board. She is also a member of several advisory boards, including the Harvard School of Public Health's Policy and Management Executive Council, the New York City Age-Friendly Commission, the New York State Quality Advisory Committee, and Honor Technology, Inc.'s Advisory Board. Ms. Raphael co-edited the book “Home Based Care for a New Century,” was a Visiting Fellow at the King's Fund in the United Kingdom, and was listed in Crain's New York Business 50 Most Powerful Women in 2009. Ms. Raphael has an MPA from Harvard University's Kennedy School of Government. Former Dean of the Dental Institute at King's College London and Professor of Orthodontics; Former Professor of Orthodontics, Senior Vice Provost of Engineering Technology and Provost of Polytechnic Institute at New York University Dr. Rekow has been a director of Henry Schein, Inc. since 2014, and most recently served as the Dean of the Dental Institute at King's College London and Professor of Orthodontics from 2012 through 2016. From 2002 to 2012, Dr. Rekow was a Professor of Orthodontics at New York University (NYU), during which time she was Senior Vice Provost of Engineering Technology at NYU (2008 to 2012) and was Provost of Polytechnic Institute of NYU (2009 to 2012). Dr. Rekow has been President of both the International Association for Dental Research and the American Association of Dental Research and, since 2000, has been an American Dental Association Consultant to the Council on Scientific Affairs. In 2011, she was elected to the Faculty of Dental Surgery of the Royal College of Surgeons (England). Dr. Rekow is an internationally known authority on the performance of new materials and products for use in aesthetic and restorative dentistry and was one of the early pioneers in digital dentistry, capitalizing on her engineering education and industry experience. Dr. Rekow's team has also carried out research into the use of bio-engineered tissue to facilitate bone replacement in people who have been disfigured by disease or developmental defects. Dr. Rekow holds a number of patents in the dental field and is the author of, or contributor to, more than 100 publications. Former CEO, Reliant Pharmaceuticals; and Former President of U.S. Human Health for Merck & Co. Dr. Sheares has been a director of Henry Schein, Inc. since 2010. He most recently served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., leading that company from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co., Inc. from 2001 until 2006, the culmination of a 19-year career with that company. Dr. Sheares is the former chair of the Board of Directors of the National Pharmaceutical Council, which focuses on broadly communicating the economic, clinical, and societal value of pharmaceuticals. He also serves as a director of Honeywell International and is a member of its management development and compensation committee and retirement plan committee. Dr. Sheares is also a director and Chairman of the compensation committee of The Progressive Corporation. Dr. Sheares holds a bachelor's degree in chemistry from Fisk University and earned his doctorate in biochemistry from Purdue University. He completed his postdoctoral training as a Lucille P. Markey Scholar and was a National Institutes of Health Postdoctoral Fellow at the Massachusetts Institute of Technology.